|[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]|
Is the U.S. really slower than Europe in approving new drugs?
Thu, 17 Mar 2011 08:21:00 -0500
FDA answers this question with a series of charts and graphs that show that, on average, FDA has approved more novel new drugs, has approved these drugs more quickly, and has enabled these drugs to come to market sooner than has its European counterpart, the European Medicines Agency (EMA).
Manage Preferences | Unsubscribe | Help with this service
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420